Can-Fite Biopharma GAAP EPS of $0.00 beats by $0.14, revenue of $0.2M in-line

May 26, 2022 7:32 AM ETCan-Fite BioPharma Ltd. (CANF)By: Deepa Sarvaiya, SA News Editor
  • Can-Fite Biopharma press release (NYSE:CANF): Q1 GAAP EPS of $0.00 beats by $0.14.
  • Revenue of $0.2M (+33.3% Y/Y) in-line.